C12N 2810/6072
Negative strand rna viruses
Official title: negative strand RNA viruses
C12N2810/6072 (Negative strand rna viruses) appears on 144 US grants and 267 published applications in this corpus.
Search patents in C12N- Granted patents
- 144
- Published applications
- 267
- Assignees
- 162
- Inventors
- 451
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 2 |
| 2002 | 2 | 8 |
| 2003 | 0 | 14 |
| 2004 | 3 | 9 |
| 2005 | 0 | 10 |
| 2006 | 6 | 17 |
| 2007 | 8 | 9 |
| 2008 | 3 | 11 |
| 2009 | 2 | 8 |
| 2010 | 3 | 18 |
| 2011 | 3 | 7 |
| 2012 | 7 | 12 |
| 2013 | 4 | 9 |
| 2014 | 11 | 10 |
| 2015 | 7 | 17 |
| 2016 | 7 | 14 |
| 2017 | 12 | 12 |
| 2018 | 13 | 17 |
| 2019 | 12 | 13 |
| 2020 | 9 | 9 |
| 2021 | 3 | 12 |
| 2022 | 2 | 5 |
| 2023 | 8 | 5 |
| 2024 | 4 | 10 |
| 2025 | 7 | 6 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Use of microvesicles in the treatment of medical conditions16 Dec 2025US 12,497,631 B2The General Hospital Corporation
- Method for improving retroviral transduction and gene editing in hematopoietic stem cells using clyclosporin H and UM1712 Dec 2025US 12,485,187 B2Fondazione Telethon
- Methods and compositions for the activation of gamma-delta T-cells2 Sep 2025US 12,403,155 B2American Gene Technologies International Inc.
- Retroviral transduction using poloxamers12 Aug 2025US 12,385,066 B2
- Immortalization of splenic and peripheral blood macrophages using a multi-cistronic v-raf/v-myc lentivirus22 Jul 2025US 12,365,917 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Pseudotyped viral particles for targeting tcr-expressing cells6 Aug 2026US 2026/0226500 A1Regeneron Pharmaceuticals, Inc.
- Targeting vector, preparation method therefor and use thereof21 May 2026US 2026/0137811 A1Shenzhen Genocury Biotech Co., Ltd.
- Delivery of heterologous proteins26 Feb 2026US 2026/0055146 A1Sana Biotechnology, Inc.
- Retroviral vectors5 Jun 2025US 2025/0177574 A1IP2Ipo Innovations Limited
- Cd3-targeted lentiviral vectors and uses thereof15 May 2025US 2025/0152709 A1Sana Biotechnology, Inc.
Most cited
By later US patents
- Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus184US 5,994,106 AGenVec, Inc. · 1999
- Liposome methods and compositions136US 4,663,161 A1987
- Complementary adenoviral systems and cell lines125US 5,851,806 AGenVec, Inc. · 1998
- Polynucleotide delivering complex for target cell86US 8,759,103 B2Postech Academy-Industry Foundation · 2014
- Reconstituting viral glycoproteins into large phospholipid vesicles62US 4,871,488 AAlbany Medical College of Union University · 1989